2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-,
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione,
CC 5013,
CC-5013,
CC5013,
IMiD3 cpd,
lenalidomide,
Revimid,
Revlimid,
Lenalidomide,
191732-72-6,
Revlimid,
Revimid,
CC-5013,
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione,
Lenalidomide (CC-5013),
CDC 501,
IMiD3,
CC 5013,
CDC-501,
Revlimid (lenalidomide),
3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione,
2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-,
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione,
Revlimid (TN),
CHEBI:63791,
NCGC00167491-01,
AK-47482,
3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione,
DSSTox_CID_26664,
DSSTox_RID_81806,
DSSTox_GSID_46664,
Q-101410,
Lenalidomide [USAN],
3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione,
Revlimid (Celgene),
CAS-191732-72-6,
Lenalidomide (USAN/INN),
Lenalidomide [USAN:INN:BAN],
(3S)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione,
ENMD 0997,
ENMD-0997,
HSDB 8220,
IMID-5013,
CDC-5013,
ALBB-015321,
IMid-1,
PubChem19113,
CHEMBL848,
Revlimid (TN) (Celgene),
AC1L50II,
SCHEMBL32978,
MLS003899194,
GTPL7331,
SCHEMBL1980410,
1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline,
DTXSID8046664,
BDBM65454,
CTK8E1915,
KS-00000GHH,
2,6-piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, (3S)-,
GOTYRUGSSMKFNF-UHFFFAOYSA-N,
3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione,
BCPP000186,
HMS3654G07,
BCP01390,
HY-A0003,
Revlimid, Lenalidomide, CC-5013,
ZX-AN014029,
Tox21_112492,
ABP001089,
AC-914,
MFCD07772307,
NSC747972,
s1029,
STK639603,
AKOS005146276,
AKOS005174869,
Tox21_112492_1,
ACN-034469,
AN-1103,
API0003142,
BCP9000847,
CS-0125,
DB00480,
KS-1207,
MCULE-9771679074,
NSC-747972,
RTR-008901,
NCGC00167491-02,
NCGC00167491-03,
NCGC00167491-04,
BC220870,
BR-47482,
SMR002529986,
SY047646,
AB0017965,
AX8136128,
LS-184040,
TR-008901,
AM20050439,
FT-0659651,
FT-0670758,
SW218084-2,
T5245,
EC-000.2340,
MFCD07772307 (97%),
D04687,
S-4172,
AB01273975-01,
AB01273975-02,
AB01273975_03,
732L726,
SR-01000883999,
I06-0831,
SR-01000883999-1,
3-(4-Amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione,
3-(4-amino-1-oxo-isoindolin-2-yl)piperidine-2,6-dione,
Z1741976709,
2, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-,
3-(4-amino-1,3-dihydro-1-oxo-2h-isoindol-2-yl)-2,6-piperidinedione,
3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-dioxopiperidine,
3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-piperidinedione,
4-amino-2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one,
443912-14-9,
Revamid,
IMiD3cpd,
Lenalidomide hydrate,
IMiD3 cpd,
Lenalidomide hydrochloride,
D0Q5NX,
Lenalidomide Celgene Europe,
Thalidomide analog CC-5013,
UNII-F0P408N6V4,
Celgene brand of lenalidomide,
Lenalidomide (Immunomodulator),
CC5013,
C13H13N3O3,
F0P408N6V4,
CC-5013, Revlimid, Lenalidomide,
CID216326,
C13-H13-N3-O3,
CC-4047,
CS-O-30619,
Lenalidomide, 98% - 500mg 500mg,
R055,
A3547,
A4211,
C467567,
D000077269,
2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-,
3-(4-Amino-1,3-dihydro-1-oxo-2H-is-oindol-2-yl)-2,6-piperidinedione,
1243329-97-6,
879126-98-4,